Table 3. Delivery outcomes . Total N =... | American Society of Hematology

Table 3.

Delivery outcomes

	Total N = 20	rVWF + TXA n = 10	rVWF n = 10	P value for treatment difference
Vaginal delivery	13 (65)	4 (40)	9 (90)	–
Cesarean delivery	7 (35)	6 (60)	1 (10)	.027
Neuraxial anesthesia	20 (100)	10 (100)	10 (100)	–
QBL at delivery, mL	633.4 (468.5)	727.0 (802.5)	539.7(355.1)	.41
QBL of >1000 mL	4 (20)	3 (30)	1 (10)	.25
Obstetrician managed for bleeding∗	6 (30)	3 (30)	(30)	–
Cumulative 21-d pictorial bleeding assessment tool†	402.7 (344.0)	467.1 (442.0)	344.8 (315.5)	.32

	Total N = 20	rVWF + TXA n = 10	rVWF n = 10	P value for treatment difference
Vaginal delivery	13 (65)	4 (40)	9 (90)	–
Cesarean delivery	7 (35)	6 (60)	1 (10)	.027
Neuraxial anesthesia	20 (100)	10 (100)	10 (100)	–
QBL at delivery, mL	633.4 (468.5)	727.0 (802.5)	539.7(355.1)	.41
QBL of >1000 mL	4 (20)	3 (30)	1 (10)	.25
Obstetrician managed for bleeding∗	6 (30)	3 (30)	(30)	–
Cumulative 21-d pictorial bleeding assessment tool†	402.7 (344.0)	467.1 (442.0)	344.8 (315.5)	.32

Data are mean (median) or n (%).

∗

Treating obstetrician–initiated management for increased bleeding clinical concern for PPH.

†

Patient-reported cumulative 21-day PBAC for lochial blood loss after delivery; participant 10 in the rVWF +TA group did not complete a PBAC diary and was excluded.

View Large

This Feature Is Available To Subscribers Only